Skip to main navigation Skip to search Skip to main content

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.

Translated title of the contribution: Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
  • V. Ratanatharathorn
  • , B. Logan
  • , D. Wang
  • , M. Horowitz
  • , J.P. Uberti
  • , O. Ringden
  • , R.P. Gale
  • , H. Khoury
  • , M. Arora
  • , S. Spellman
  • , C. Cutler
  • , J. Antin
  • , M. Bornhaüser
  • , G. Hale
  • , L.F. Verdonck
  • , M. Cairo
  • , V. Gupta
  • , x CIBMTR
  • , S. Pavletic

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPrior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
Original languageUndefined/Unknown
Pages (from-to)816-824
Number of pages9
JournalBritish Journal of Haematology
Volume145
Issue number6
Publication statusPublished - 2009

Cite this